NCT07109362View on ClinicalTrials.gov

ERP-Based Research on the Modulation of Remimazolam on Working Memory and Brain Network Mechanisms in Glioma Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 10, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

July 30, 2026

Conditions
Remimazolam Mild SedationHealthy Brain and Glioma Brain
Interventions
DRUG

mild sedation

In this experiment, all subjects were administered remimazolam via a TCI pump until they reached a state of mild sedation, as indicated by a MOAA/S score of 4.

Trial Locations (1)

100070

Beijing Tiantan Hospital, Beijing

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER

NCT07109362 - ERP-Based Research on the Modulation of Remimazolam on Working Memory and Brain Network Mechanisms in Glioma Patients | Biotech Hunter | Biotech Hunter